TP53 and acute lymphoblastic leukemia: In another study, immunohistochemical expression of p53 was evaluated in bone marrow samples from two groups at the time of diagnosis: (1) 30 children with ALL who survived disease-free for at least 5 years and (2) 15 advanced ALL patients admitted for bone marrow transplant (BMT).